TY - JOUR
T1 - Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital
AU - Marschall, Jonas
AU - Piccirillo, Marilyn L.
AU - Foxman, Betsy
AU - Zhang, Lixin
AU - Warren, David K.
AU - Henderson, Jeffrey P.
N1 - Funding Information:
JM received support from the NIH CTSA (UL1RR024992) in form of a KL2 Career Development Grant (KL2RR024994), and is currently the recipient of a Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) award through the NIH NCATS, a career development award (5K12HD001459-13). He is also the section leader for a subproject of the CDC Prevention Epicenters Program grant (U54 CK000162; PI Fraser). In addition, JM is funded by the Barnes-Jewish Hospital Patient Safety & Quality Fellowship Program and a Washington University Institute of Clinical and Translational Sciences (ICTS) research grant. LZ is supported in part by a UM MICHR CTSA grant (UL1RR024986). BF is supported in part by an interdisciplinary training program grant at the University of Michigan (5T32AI049816-10), by NICHD (5R01HD038098-07) and NIDDK (5R21DK085290-02). JPH holds a career award for medical scientists from the Burroughs-Wellcome Fund and receives additional support from NIH HD000459-09 and HL101263-01. DKW is supported in part by a CDC Prevention Epicenter Program grant (CDC 1U1CI000033301). We thank Kyle Ota who assisted with the collection of patient data, and Cherie Hill and Dorothy Sinclair for their invaluable help with data management. The study would also not have been possible without Joan Hoppe-Bauer and Linda Chase who were instrumental in setting up the isolate identification and storage system. In Ann Arbor, Sreelatha Ponnaluri organized the isolate storage, and Mikiko Senga helped with DNA extraction in preparation for the microarray analyses.
Funding Information:
None of the following authors has a conflict of interest (J Marschall: no conflict, ML Piccirillo: no conflict, JP Henderson: no conflict). DK Warren is a Consultant for 3 M Healthcare and Cardinal Health, Inc., and receives research funding from Sage Products, Inc., 3 M Healthcare, BioMérieux, and Cubist Pharmaceuticals.
PY - 2013/5/10
Y1 - 2013/5/10
N2 - Background: Escherichia coli is a common cause of asymptomatic and symptomatic bacteriuria in hospitalized patients. Asymptomatic bacteriuria (ASB) is frequently treated with antibiotics without a clear indication. Our goal was to determine patient and pathogen factors suggestive of ASB.Methods: We conducted a 12-month prospective cohort study of adult inpatients with E. coli bacteriuria seen at a tertiary care hospital in St. Louis, Missouri, USA. Urine cultures were taken at the discretion of treating physicians. Bacterial isolates were tested for 14 putative virulence genes using high-throughput dot-blot hybridization.Results: The median age of the 287 study patients was 65 (19-101) years; 78% were female. Seventy percent had community-acquired bacteriuria. One-hundred ten (38.3%) patients had ASB and 177 (61.7%) had symptomatic urinary tract infection (sUTI). Asymptomatic patients were more likely than symptomatic patients to have congestive heart failure (p = 0.03), a history of myocardial infarction (p = 0.01), chronic pulmonary disease (p = 0.045), peripheral vascular disease (p = 0.04), and dementia (p = 0.03). Patients with sUTI were more likely to be neutropenic at the time of bacteriuria (p = 0.046). Chronic pulmonary disease [OR 2.1 (95% CI 1.04, 4.1)] and dementia [OR 2.4 (95% CI 1.02, 5.8)] were independent predictors for asymptomatic bacteriuria. Absence of pyuria was not predictive of ASB. None of the individual virulence genes tested were associated with ASB nor was the total number of genes.Conclusions: Asymptomatic E. coli bacteriuria in hospitalized patients was frequent and more common in patients with dementia and chronic pulmonary disease. Bacterial virulence factors could not discriminate symptomatic from asymptomatic bacteriurias. Asymptomatic E. coli bacteriuria cannot be predicted by virulence screening.
AB - Background: Escherichia coli is a common cause of asymptomatic and symptomatic bacteriuria in hospitalized patients. Asymptomatic bacteriuria (ASB) is frequently treated with antibiotics without a clear indication. Our goal was to determine patient and pathogen factors suggestive of ASB.Methods: We conducted a 12-month prospective cohort study of adult inpatients with E. coli bacteriuria seen at a tertiary care hospital in St. Louis, Missouri, USA. Urine cultures were taken at the discretion of treating physicians. Bacterial isolates were tested for 14 putative virulence genes using high-throughput dot-blot hybridization.Results: The median age of the 287 study patients was 65 (19-101) years; 78% were female. Seventy percent had community-acquired bacteriuria. One-hundred ten (38.3%) patients had ASB and 177 (61.7%) had symptomatic urinary tract infection (sUTI). Asymptomatic patients were more likely than symptomatic patients to have congestive heart failure (p = 0.03), a history of myocardial infarction (p = 0.01), chronic pulmonary disease (p = 0.045), peripheral vascular disease (p = 0.04), and dementia (p = 0.03). Patients with sUTI were more likely to be neutropenic at the time of bacteriuria (p = 0.046). Chronic pulmonary disease [OR 2.1 (95% CI 1.04, 4.1)] and dementia [OR 2.4 (95% CI 1.02, 5.8)] were independent predictors for asymptomatic bacteriuria. Absence of pyuria was not predictive of ASB. None of the individual virulence genes tested were associated with ASB nor was the total number of genes.Conclusions: Asymptomatic E. coli bacteriuria in hospitalized patients was frequent and more common in patients with dementia and chronic pulmonary disease. Bacterial virulence factors could not discriminate symptomatic from asymptomatic bacteriurias. Asymptomatic E. coli bacteriuria cannot be predicted by virulence screening.
KW - Asymptomatic
KW - Bacteriuria
KW - Escherichia coli
KW - Urinary tract infection
KW - Virulence factors
UR - http://www.scopus.com/inward/record.url?scp=84877302428&partnerID=8YFLogxK
U2 - 10.1186/1471-2334-13-213
DO - 10.1186/1471-2334-13-213
M3 - Article
C2 - 23663267
AN - SCOPUS:84877302428
SN - 1471-2334
VL - 13
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 213
ER -